Cargando…

Characterization of the Expression of the RNA Binding Protein eIF4G1 and Its Clinicopathological Correlation with Serous Ovarian Cancer

BACKGROUND: Ovarian cancer is the most lethal type of malignant tumor in gynecological cancers and is associated with a high percentage of late diagnosis and chemotherapy resistance. Thus, it is urgent to identify a tumor marker or a molecular target that allows early detection and effective treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lanfang, Luo, Qingya, Xie, Zhe, Li, Guiqin, Mao, Chengyi, Liu, Yi, Wen, Xin, Yin, Na, Cao, Jianzhong, Wang, Jing, Li, Li, Yu, Jianhua, Wang, Fang, Yi, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036801/ https://www.ncbi.nlm.nih.gov/pubmed/27668427 http://dx.doi.org/10.1371/journal.pone.0163447

Ejemplares similares

The m(6)A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
por: Liu, Tao, et al.
Publicado: (2020)

Correlation of FOXC1 protein with clinicopathological features in serous ovarian tumors
por: WANG, LU-YING, et al.
Publicado: (2016)

The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ
por: Liu, Tao, et al.
Publicado: (2021)

PHLDA1 Modulates the Endoplasmic Reticulum Stress Response and is required for Resistance to Oxidative Stress-induced Cell Death in Human Ovarian Cancer Cells
por: Xu, Jing, et al.
Publicado: (2021)

Structural motifs in eIF4G and 4E-BPs modulate their binding to eIF4E to regulate translation initiation in yeast
por: Grüner, Stefan, et al.
Publicado: (2018)

Human Translation Initiation Factor eIF4G1 Possesses a Low-Affinity ATP Binding Site Facing the ATP-Binding Cleft of eIF4A in the eIF4G/eIF4A Complex
por: Akabayov, Sabine R., et al.
Publicado: (2014)

The significance of the alteration of 8-OHdG in serous ovarian carcinoma
por: Xu, Xia, et al.
Publicado: (2013)

Early stage primary ovarian mucinous carcinoma: Outcome-based clinicopathological study in comparison with serous carcinoma
por: Tian, Qifang, et al.
Publicado: (2016)

p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: A retrospective study
por: ZHANG, PENG, et al.
Publicado: (2015)

Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis
por: Su, Kuo-Min, et al.
Publicado: (2021)

Clinicopathologic and survival results in serous endometrium carcinoma and subgroup analysis for mixed serous and pure serous histology
por: Kaban, Alpaslan, et al.
Publicado: (2018)

Synergistic activation of eIF4A by eIF4B and eIF4G
por: Nielsen, Klaus H., et al.
Publicado: (2011)

Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian Cancer
por: Wang, Yicheng, et al.
Publicado: (2022)

eIF4F-like complexes formed by cap-binding homolog TbEIF4E5 with TbEIF4G1 or TbEIF4G2 are implicated in post-transcriptional regulation in Trypanosoma brucei
por: Freire, Eden R., et al.
Publicado: (2014)

SUMO-2 Promotes mRNA Translation by Enhancing Interaction between eIF4E and eIF4G
por: Chen, Li-zhao, et al.
Publicado: (2014)

Development of a novel transcription factors-related prognostic signature for serous ovarian cancer
por: Li, He, et al.
Publicado: (2021)

Identification of a 3-mRNA signature as a novel potential prognostic biomarker in patients with ovarian serous cystadenocarcinoma in G2 and G3
por: Zhou, Jiahua, et al.
Publicado: (2019)

Expression and clinical significance of methyl-CpG binding domain protein 2 in high-grade serous ovarian cancer
por: Gong, Wangang, et al.
Publicado: (2020)

Identification of an Individualized Prognostic Biomarker for Serous Ovarian Cancer: A Qualitative Model
por: Luo, Fengyuan, et al.
Publicado: (2022)

Efficacy of Postoperative Hormone Replacement Therapy on Prognosis of Patients with Serous Ovarian Carcinoma
por: Zhang, Yong-Li, et al.
Publicado: (2016)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer
por: Chen, Xueping, et al.
Publicado: (2022)

eIF4G has intrinsic G-quadruplex binding activity that is required for tiRNA function
por: Lyons, Shawn M, et al.
Publicado: (2020)

eIF4E Overexpression Is Associated with Poor Prognoses of Ovarian Cancer
por: Zheng, Jun, et al.
Publicado: (2020)

Spatial patterns of the cap-binding complex eIF4F in human melanoma cells
por: Tang, Xinpu, et al.
Publicado: (2023)

EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer
por: Li, Kun, et al.
Publicado: (2022)

Analysis of EIF4G1 in ethnic Chinese
por: Li, Kai, et al.
Publicado: (2013)

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
por: Li, Jie, et al.
Publicado: (2012)

Serous carcinoma of the uterine cervix: Clinicopathological features differing from serous carcinomas of other female organs
por: Kitade, Shoko, et al.
Publicado: (2019)

Loss-of-Function Analysis Reveals Distinct Requirements of the Translation Initiation Factors eIF4E, eIF4E-3, eIF4G and eIF4G2 in Drosophila Spermatogenesis
por: Ghosh, Sanjay, et al.
Publicado: (2015)

Binding of eIF3 in complex with eIF5 and eIF1 to the 40S ribosomal subunit is accompanied by dramatic structural changes
por: Zeman, Jakub, et al.
Publicado: (2019)

Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics Data
por: Zhang, Zhe, et al.
Publicado: (2016)

Recurrence characteristics and clinicopathological results of borderline ovarian tumors
por: Niu, Lina, et al.
Publicado: (2021)

Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer
por: Si, Manfei, et al.
Publicado: (2019)

Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma
por: Zhang, Jun, et al.
Publicado: (2017)

Eukaryotic initiation factor 4B and the poly(A)-binding protein bind eIF4G competitively
por: Cheng, Shijun, et al.
Publicado: (2013)

Identification of clinical and molecular features of recurrent serous borderline ovarian tumour
por: Lu, Ziyang, et al.
Publicado: (2022)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

eIF4B, eIF4G and RNA regulate eIF4A activity in translation initiation by modulating the eIF4A conformational cycle
por: Harms, Ulf, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vj39ki50fk3e09cbkvnk4vkh88